Evidence map›Paper›PMID 39799963›Full record

ArticleAnnals of clinical and translational neurology2025

Demyelinating neuropathy as the initial presentation of familial E200K Creutzfeldt-Jakob disease in two patients.

Cécile Delorme, Antoine Pégat, Julian Theuriet, Jean-Philippe Brandel, Emmanuel Roze, Karine Viala, Julie Zyss, Stéphane Thobois, Anthony Fourier, Emilien Bernard and 10 more

Abstract readCase Reports
In one paragraph

Article in Annals of clinical and translational neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Cécile Delorme *Service de Neurologie, Hôpital Pitié-Salpêtrière AP-HP, Paris, France.ORCID 0000-0002-5838-9077
Antoine Pégat *Service ENMG et de Pathologies Neuromusculaires, Centre de Référence des Maladies Neuromusculaires PACA-Réunion-Rhône Alpes, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France.ORCID 0000-0003-1563-9432
Julian TheurietService ENMG et de Pathologies Neuromusculaires, Centre de Référence des Maladies Neuromusculaires PACA-Réunion-Rhône Alpes, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France.
Jean-Philippe BrandelCellule Nationale de Référence des Maladies de Creutzfeldt-Jakob, AP-HP-Sorbonne Université, Paris, France.
Emmanuel RozeService de Neurologie, Hôpital Pitié-Salpêtrière AP-HP, Paris, France.
Karine VialaDépartement de Neurophysiologie Clinique, Hôpital Pitié-Salpêtrière AP-HP, Paris, France.
Julie ZyssDépartement de Neurophysiologie Clinique, Hôpital Pitié-Salpêtrière AP-HP, Paris, France.
Stéphane ThoboisService de Neurologie C, Pathologies du Mouvement et Pathologies Neuromusculaires, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France.
Anthony FourierUnité de Diagnostic des Pathologies Dégénératives, Biochimie et Biologie Moléculaire - LBBMS, Centre de Biologie et Pathologie Est Groupement Est, Bron, France.
Emilien BernardService de Neurologie C, Pathologies du Mouvement et Pathologies Neuromusculaires, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France.
Juliette SvahnService de Neurologie C, Pathologies du Mouvement et Pathologies Neuromusculaires, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France.
Chloé LaurencinService de Neurologie C, Pathologies du Mouvement et Pathologies Neuromusculaires, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France.
Paul JaulentService de Neurologie C, Pathologies du Mouvement et Pathologies Neuromusculaires, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France.
Christophe VandendriesCentre Médical RMX, Paris, France.
Isabelle QuadrioUnité de Diagnostic des Pathologies Dégénératives, Biochimie et Biologie Moléculaire - LBBMS, Centre de Biologie et Pathologie Est Groupement Est, Bron, France.
Virginie DesestretService de Neurocognition et Neuro-ophtalmologie, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France.
David MeyronetService D'Anatomie et de Cytologie Pathologique, Centre de biologie et pathologie Est Groupement Est, Bron, France.
Thierry MaisonobeDépartement de Neurophysiologie Clinique, Hôpital Pitié-Salpêtrière AP-HP, Paris, France.
Stéphane HaïkCellule Nationale de Référence des Maladies de Creutzfeldt-Jakob, AP-HP-Sorbonne Université, Paris, France.
Danielle SeilheanInstitut du Cerveau et de la Moelle Épinière, ICM, Sorbonne Université, INSERM, CNRS, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo describe peripheral neuropathy associated with familial Creutzfeldt-Jakob disease.

methodsWe report two unrelated patients with genetic Creutzfeldt-Jakob disease with demyelinating peripheral neuropathy as initial presentation, with a comprehensive clinical, electrophysiological and neuropathological description.

resultsBoth patients exhibited gait disturbance and paresthesia. Electrodiagnostic studies revealed demyelinating abnormalities with motor conduction blocks suggestive of chronic inflammatory demyelinating polyradiculoneuropathy, with abnormal plexus MRI and elevated CSF protein levels. One of them had pes cavus and a late-onset Charcot-Marie-Tooth (CMT) disease was also initially hypothesized. Central nervous system involvement manifested 1-2 years after the onset of peripheral symptoms. Both patients had a heterozygous E200K mutation in the PRNP gene. Postmortem neuropathological examinations showed PrP

interpretationPeripheral neuropathy in E200K genetic forms of Creutzfeldt-Jakob disease can be inaugural and mimic chronic inflammatory demyelinating polyradiculoneuropathy.

Indexed as

Creutzfeldt-Jakob SyndromeDemyelinating DiseasesAgedFemaleHumansMaleMiddle AgedPrion ProteinsPrion ProteinsPRNP protein, human

Identifiers

PMID39799963
PMCPMC11920726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.